Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...